{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal stem Diabetic Foot Ulcer",
            "NStudiesAvail": 430108,
            "NStudiesFound": 26,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 26,
            "FieldList": [
                  "ResultsFirstSubmitDate",
                  "ResultsFirstSubmitQCDate",
                  "RetractionPMID",
                  "RetractionSource",
                  "SamplingMethod",
                  "SecondaryId",
                  "SecondaryIdDomain",
                  "SecondaryIdLink",
                  "SecondaryIdType",
                  "SecondaryOutcomeDescription",
                  "SecondaryOutcomeMeasure",
                  "SecondaryOutcomeTimeFrame",
                  "SeeAlsoLinkLabel",
                  "SeeAlsoLinkURL",
                  "SeriousEventAssessmentType",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "The rate of serious adverse event in 1 hour after single dose of Human placental mesenchymal stem cells gel on Human diabetic food ulcer.",
                              "Rate of cure rate in 20 days and 34 days after multi-dose of Human placental mesenchymal stem cells gel on Human diabetic food ulcer."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Rate of serious adverse event",
                              "Rate of cure rate"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "0 hour - 1 hour",
                              "0 day - 34 days"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT04464213"
                        ]
                  },
                  {
                        "Rank": 2,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "percentage of patients achieving 50 % wound closure",
                              "percentage of patients whose ulcer recurred"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Rate of healing",
                              "rate of ulcer recurrence"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "6 months",
                              "one year"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT03259217"
                        ]
                  },
                  {
                        "Rank": 3,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "1. Number and percent of subjects who develop a high titer of antibodies to human leukocyte antigen (HLA) Class I molecules expressed on Corlicyte\u00ae",
                              "2. Time to development of high titer of antibodies to HLA Class I molecules expressed on Corlicyte\u00ae",
                              "3. Number and percent of subjects with an increase in ulcer size by the end of the Treatment Phase as reviewed by the Wound Core Laboratory (WCL).",
                              "4. Number and percent of subjects with an adverse reaction to Corlicyte\u00ae in each cohort and overall.",
                              "5. Number and percent of subjects with a suspected adverse reaction to Corlicyte\u00ae in each cohort and overall.",
                              "6. Number and percent of subjects with a suspected serious adverse reaction to Corlicyte\u00ae in each cohort and overall.",
                              "7. Change in hemoglobin A1c from Screening to End-of-Study/Early Termination"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Antibodies to HLA Class I - number and percent",
                              "Antibodies to HLA Class I - Time To Development",
                              "Increase Ulcer Size",
                              "Adverse Reaction",
                              "Suspected Adverse Reaction",
                              "Suspected Serious Adverse Reaction",
                              "Change in A1c"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "throughout study completion, an average of 4 months per subject",
                              "throughout study completion, an average of 4 months per subject",
                              "throughout study completion, an average of 4 months per subject",
                              "throughout study completion, an average of 4 months per subject",
                              "throughout study completion, an average of 4 months per subject",
                              "throughout study completion, an average of 4 months per subject",
                              "throughout study completion, an average of 4 months per subject"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT04104451"
                        ]
                  },
                  {
                        "Rank": 4,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [
                              "267976/13/NCBR/2015",
                              "2016-004109-15",
                              "PL008125",
                              "Z4217"
                        ],
                        "SecondaryIdDomain": [
                              "The National Center for Research and Development, Poland",
                              "EU tissue establishment code",
                              "ISBT128 (Facility Identification Number)"
                        ],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [
                              "Other Grant/Funding Number",
                              "EudraCT Number",
                              "Other Identifier",
                              "Other Identifier"
                        ],
                        "SecondaryOutcomeDescription": [
                              "Clinical assessment of wound morphology (and its changes during the treatment) in each treated patient, as well, as between patients in both study arms, expressed as:\n\nthe amount (1) and features (2) of wound exudate,\nthe presence of redness (3) and/or edema (4) in the wound surrounding skin,\nthe presence of granular tissue and fibrin (5) or epithelium (6) in the wound bed.\n\nThe listed parameters will be assessed using simplified questionnaire adopted from Bates-Jensen Wound Assessment Tool (positions 7-13 from B-JWAT).\n\nEach of 6 abovementioned features will be assessed semiquantitatively using 1-5 points scale, (with \"1\" for a best state, and \"5\" for a worst state). The sum of points allocated to each parameter will be recorded as the wound score and used for further analysis.\n\nThe healthy skin/healed wound should receive 6 points, whereas active wound, with exudate and inflammation will receive 30 points (the lower = the better / the higher = the worse).",
                              "Evaluation of the expression (and its changes during the treatment) of selected pro-angiogenic factors, measured in wound biopsies.\n\nThe changes will be analyzed for each tested individual separately, and compared between both study arms.",
                              "Evaluation of the wound-associated pain, assessed by the patient using visual analogue scale. The minimum value is 0 and means \"no pain\" and the maximum value is 10 and means \"the worst possible pain\". The lower value the better outcome.\n\nThe changes will be analyzed for each tested individual separately, and compared between both study arms.",
                              "Evaluation of the patient's quality of life, assessed by the dedicated QoL questionnaire. The QoL questionnaire consists of 10 questions. Each question is scored 1 to 5. The minimum score is 10 and it means \"the best possible state of health\", and the maximum score is 50, which means ,,the worst possible state of health\".\n\nThe changes will be analyzed for each tested individual separately, and compared between both study arms.",
                              "Evaluation of the safety of ADSC application, assessed by the occurrence of any adverse events."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Changes in wound morphology",
                              "Changes in pro-angiogenic factors expression",
                              "Changes in wound-associated pain",
                              "Changes in the quality of life",
                              "Record of adverse events"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "8 weeks",
                              "8 weeks",
                              "8 weeks",
                              "8 weeks",
                              "8 weeks"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT03865394"
                        ]
                  },
                  {
                        "Rank": 5,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [],
                        "SecondaryOutcomeMeasure": [
                              "Proportion of re-epithelialization",
                              "Time to re-epithelialization",
                              "Number of Participants with Adverse Events as a Measure of Safety and Tolerability"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "During 12 weeks",
                              "During 12 weeks",
                              "Follow up to 12 weeks"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT02619877"
                        ]
                  },
                  {
                        "Rank": 6,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Time to initial complete wound closure between the two groups",
                              "Wound size is measured by using eKare 3D Wound Measurement system(Mobile Devices)",
                              "Proportions of subjects who achieved complete wound closure",
                              "Wound size is measured by using eKare 3D Wound Measurement system(Mobile Devices)"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Time to initial complete wound closure between the two groups",
                              "Changes in wound size compared to baseline between the two groups",
                              "Proportions of subjects who achieved complete wound closure by the classification of location of diabetic foot ulcer, Plantar and the other location between the two groups",
                              "Durability of complete wound closure"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "During 12 weeks",
                              "During 12 weeks",
                              "During 12 weeks(at every visit during treatment period)",
                              "Follow up to 24 weeks from the initial complete wound closure."
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT03754465"
                        ]
                  },
                  {
                        "Rank": 7,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "cm^2"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Time taken to complete wound closure between the two groups",
                              "Proportions of subjects who achieved complete wound closure",
                              "Proportions of subjects who achieved complete wound closure by the classification of Wagner Grade between the two groups",
                              "Change rates in wound size and depth compared to baseline between the two groups",
                              "Proportions of subjects who achieved complete wound closure at every visit by the classification of ulcer locations"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "During 12 weeks",
                              "Follow up to 12 weeks",
                              "Follow up to 12 weeks",
                              "During 12 weeks",
                              "Follow up to 12 weeks"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT03370874"
                        ]
                  },
                  {
                        "Rank": 8,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Improvement of local perfusion.",
                              "Measure of the subjective symptom of pain."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Improvement of transcutaneous oxygen partial pressure (TcPO2)",
                              "Improvement of microvascular cutaneous reactivity by laser Doppler perfusion monitoring (LDPM)",
                              "Pain (Visual-Analog Scale)",
                              "Walking distance (treadmill) if possible"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "3 months",
                              "3 months",
                              "3 months",
                              "3 months"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT02834858"
                        ]
                  },
                  {
                        "Rank": 9,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Measure the time to initial complete wound closure between the 2 groups.",
                              "Wound size is measured by using eKare 3D Wound Measurement system(Mobile Devices).",
                              "Proportions of subjects who achieved complete wound closure by the classification of wound size, 1.5~7 cm2 and 7.1~15 cm2 between the 2 groups at every visit.",
                              "Proportions of subjects who achieved complete wound closure by the classification of location of diabetic foot ulcer, plantar and dorsal between the 2 groups at every visit by post-hoc analysis.",
                              "Durability of complete wound closure for the additional 24 weeks from the initial complete wound closure.\n\nWound size is measured by using eKare 3D Wound Measurement system(Mobile Devices)."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Time to initial complete wound closure between the 2 groups.",
                              "Changes in wound size compared to baseline between the 2 groups.",
                              "Proportions of subjects who achieved complete wound closure between the 2 groups by the classification of wound size.",
                              "Proportions of subjects who achieved complete wound closure between the 2 groups by the classification of location of diabetic foot ulcer.",
                              "Durability of complete wound closure for the additional 24 weeks."
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "During 12 weeks",
                              "During 12 weeks",
                              "During 12 weeks",
                              "During 12 weeks",
                              "During 36 weeks"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT04497805"
                        ]
                  },
                  {
                        "Rank": 10,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Wound healing time",
                              "Transcutaneous oxygen partial pressure"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Wound healing time",
                              "Transcutaneous oxygen partial pressure"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "up to 6 months",
                              "Transcutaneous oxygen partial pressure up to 6 months"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT03248466"
                        ]
                  },
                  {
                        "Rank": 11,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [
                              "Probability Sample"
                        ],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Evaluation of the improvement of wound measured by size and depth, and examines the change for 23 months period"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Wound size and depth measurement"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "6, 12, 24 months"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT03183726"
                        ]
                  },
                  {
                        "Rank": 12,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Improvement of local perfusion.",
                              "Measure of the subjective symptom of pain."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Improvement of transcutaneous oxygen partial pressure (TcPO2)",
                              "Improvement of microvascular cutaneous reactivity by laser Doppler perfusion monitoring (LDPM)",
                              "Pain (Visual-Analog Scale)",
                              "Walking distance (treadmill) if possible"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "3 months",
                              "3 months",
                              "3 months",
                              "3 months"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT02796079"
                        ]
                  },
                  {
                        "Rank": 13,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [
                              "Probability Sample"
                        ],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [],
                        "SecondaryOutcomeMeasure": [],
                        "SecondaryOutcomeTimeFrame": [],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT03183804"
                        ]
                  },
                  {
                        "Rank": 14,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [],
                        "SecondaryOutcomeMeasure": [],
                        "SecondaryOutcomeTimeFrame": [],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT00955669"
                        ]
                  },
                  {
                        "Rank": 15,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Evaluation of the improvement of wound measured by size and depth, and examines the change for 4 weeks period."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Wound size and depth measurement"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "baseline and 1, 2, 4 weeks"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT02394886"
                        ]
                  },
                  {
                        "Rank": 16,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [
                              "20710046"
                        ],
                        "RetractionSource": [
                              "de la Fuente R, Bernad A, Garcia-Castro J, Martin MC, Cigudosa JC. Cancer Res. 2010 Aug 15;70(16):6682"
                        ],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [],
                        "SecondaryOutcomeMeasure": [],
                        "SecondaryOutcomeTimeFrame": [],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT01686139"
                        ]
                  },
                  {
                        "Rank": 17,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [],
                        "SecondaryOutcomeMeasure": [
                              "Percentage of area change of study ulcer from baseline to weeks 12 and 24",
                              "Number of days to complete ulcer healing",
                              "Number of days to 50% ulcer healing",
                              "Percentage change in ulcer volume from baseline to weeks 12 and 24",
                              "Changes from baseline in ulcer pain assessed using a Numeric Rating Scale",
                              "Number clinic/home care visits across groups",
                              "Differences across groups on ulcer dressing products used",
                              "Changes from baseline in Quality of Life assessed using the Cardiff Wound Impact Schedule",
                              "Duration of clinic/home care visits across groups"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "12 and 24 weeks",
                              "12 and 24 weeks",
                              "12 and 24 weeks",
                              "12 and 24 weeks",
                              "12 and 24 weeks",
                              "12 and 24 weeks",
                              "12 and 24 weeks",
                              "12 and 24 weeks",
                              "12 and 24 weeks"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT05165628"
                        ]
                  },
                  {
                        "Rank": 18,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [],
                        "SecondaryOutcomeMeasure": [
                              "Scar outcome assessment",
                              "Incidence of contracture release or revision surgeries",
                              "Incidence of increased temperature sensitivity",
                              "Incidence of paresthesias, pain, dulling of sensation assessed",
                              "Incidence and severity of infections at grafting sites",
                              "Incidence of all adverse events",
                              "Percentage area of re-grafting as determined"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "Up to Month 36 after the last grafting day",
                              "Up to Month 36 after the last grafting day",
                              "Up to Month 36 after the last grafting day",
                              "Up to Month 36 after the last grafting day",
                              "Up to Month 6 after the last grafting day",
                              "Up to Month 36 after the last grafting day",
                              "Up to Month 6 after the last grafting day"
                        ],
                        "SeeAlsoLinkLabel": [
                              "Related Info"
                        ],
                        "SeeAlsoLinkURL": [
                              "http://link.springer.com/article/10.1007%2Fs11427-007-0069-2"
                        ],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT02672280"
                        ]
                  },
                  {
                        "Rank": 19,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [],
                        "SecondaryOutcomeMeasure": [
                              "Time taken to complete wound closure",
                              "Proportions of subjects who achieved complete wound closure at every visit",
                              "Change rates in wound size and depth compared to baseline groups"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "During 12 weeks",
                              "During 12 weeks",
                              "During 12 weeks"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT04569409"
                        ]
                  },
                  {
                        "Rank": 20,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Improvement of local perfusion.",
                              "Measure of the subjective symptom of pain."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Improvement of transcutaneous oxygen partial pressure (TcPO2)",
                              "Improvement of microvascular cutaneous reactivity by laser Doppler perfusion monitoring (LDPM)",
                              "Pain (Visual-Analog Scale)",
                              "Walking distance (treadmill) if possible"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "3 months",
                              "3 months",
                              "3 months",
                              "3 months"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT02831075"
                        ]
                  },
                  {
                        "Rank": 21,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Percentage of wound surface area reduction will be evaluated.",
                              "Percentage of invisible and visible wound surface area reduction will be evaluated.",
                              "Absolute wound surface area reduction will be evaluated.",
                              "Absolute invisible and visible wound surface area reduction will be evaluated.",
                              "Wound infection will be evaluated.",
                              "Time to first complete wound closure will be evaluated.",
                              "Proportion of patients achieving complete wound closure will be evaluated.",
                              "Time to first 30% reduction of wound surface area will be evaluated.",
                              "Proportion of patients achieving 30% reduction of wound surface area will be evaluated.",
                              "Wound exudation, epithelialization and formation of granulation tissue will be evaluated.",
                              "Time to amputation at target leg until week 12 will be evaluated.",
                              "Pain assessment as per numerical rating scale (NRS) will be evaluated.",
                              "Quality of life (QoL) using the short form 36 (SF-36) questionnaire will be evaluated.",
                              "Dermatology-specific QoL based on the Dermatology Life Quality Index (DLQI) questionnaire will be evaluated.",
                              "Physical examination and vital signs will be evaluated.",
                              "Time to amputation of target leg until month 12 will be evaluated."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Percentage of wound surface area reduction",
                              "Percentage of invisible and visible wound surface area reduction",
                              "Absolute wound surface area reduction",
                              "Absolute invisible and visible wound surface area reduction",
                              "Assessment of wound infection",
                              "Time to first complete wound closure",
                              "Proportion of patients achieving complete wound closure",
                              "Time to first 30% reduction of wound surface area",
                              "Proportion of patients achieving 30% reduction of wound surface area",
                              "Assessment of wound exudation, epithelialization and formation of granulation tissue",
                              "Time to amputation at target leg until Week 12",
                              "Pain assessment as per numerical rating scale (NRS)",
                              "Assessment of Quality of life (QoL) using the short form 36 (SF-36) questionnaire",
                              "Assessment of Dermatology-specific QoL based on the Dermatology Life Quality Index (DLQI) questionnaire",
                              "Physical examination and vital signs",
                              "Time to amputation of target leg until month 12"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "Weeks 2, 4, 6, 8 and 12 (without LOCF)",
                              "Weeks 2, 4, 6, 8 and 12 (without LOCF)",
                              "Weeks 2, 4, 6, 8 and 12 (without LOCF)",
                              "Weeks 2, 4, 6, 8 and 12 (without LOCF)",
                              "Days 1 and 2, Weeks 1, 2, 4, 6, 6.1, 6.2, 6.3, 8 and 12",
                              "A priori specification not possible; between baseline and week 12 post baseline",
                              "Weeks 2, 4, 6, 8 and 12",
                              "A priori specification not possible; between baseline and week 12 post baseline",
                              "Weeks 2, 4, 6, 8 and 12",
                              "Day 0 and Week 6.1 prior IMP-application, at Weeks 1, 2, 4, 6, 8 and 12",
                              "A priori specification not possible; between baseline and week 12 post baseline",
                              "At both Screening Visits, at Days 0, 1 and 2 and at Weeks 1, 2, 4, 6, 6.1, 6.2, 6.3, 8 and 12",
                              "Screening Visit 1, Visit 3, at Weeks 4 and 12",
                              "Screening Visit 1, Visit 3, at Weeks 4 and 12",
                              "Week 6.1 and Week 12",
                              "A priori specification not possible; between baseline and month 12 post baseline"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT03267784"
                        ]
                  },
                  {
                        "Rank": 22,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [],
                        "SecondaryOutcomeMeasure": [
                              "Pain",
                              "Ankle-Brachial pressure index",
                              "Wound healing (wound size, wound stage)",
                              "Walking distance",
                              "Rate and extent of amputations"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "3 months",
                              "3 months",
                              "3 months",
                              "3 months",
                              "6 months"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT01216865"
                        ]
                  },
                  {
                        "Rank": 23,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Percentage of patients achieving 50% wound closure at Day 28",
                              "The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.",
                              "Improvement Wound pain visual analogue scale (VAS)"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Wound closure at Day 28",
                              "Improvement of Quality of Life (QoL) - EQ-5D-5L",
                              "Improvement Wound pain"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "28 days",
                              "25 days",
                              "28 days"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT05274295"
                        ]
                  },
                  {
                        "Rank": 24,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [],
                        "SecondaryOutcomeMeasure": [
                              "Rate major amputations Rate of patients with complete ulcer healing Rate of treatment related complications Improvement of ankle brachial index (ABI) Improvement of transcutaneous oxygen partial pressure (TcPO2) Improvement of local perfusion"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "12 months"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT01065337"
                        ]
                  },
                  {
                        "Rank": 25,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Change from baseline in nutritional status assessed from blood samples",
                              "Change from baseline in haemogram assessed from blood samples",
                              "Change from baseline in HbA1c (%) assessed from blood samples",
                              "Change from baseline in thyrotropin (mlU/L) assessed from blood samples",
                              "Change from baseline in CRP (mg/L) assessed from blood samples",
                              "Change from baseline in total CD34+ or CD133+ cells expressing vascular endothelial growth factor receptor 2 (VEGFR2) analyzed by flow cytometry",
                              "Change from baseline in concentration of SDF-1 and VEGFA factors in serum by ELISA"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Composite measure of markers of nutritional status",
                              "Composite measure of haemogram",
                              "Hemoglobin A1c (HbA1c) Test for Diabetes",
                              "Measure of markers of nutritional status, include to thyrotropin",
                              "Ultrasensitive C-reactive Protein (CRP) test",
                              "Quantification of circulating endothelial progenitor cells (EPC)",
                              "Concentration of stromal cell-derived factor 1 (SDF-1) and vascular endothelial growth factor A (VEGFA)"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "Baseline, 30 days after treatment initiation, 60 days after treatment initiation and 90 days after treatment initiation",
                              "Baseline, 30 days after treatment initiation, 60 days after treatment initiation and 90 days after treatment initiation",
                              "Baseline, 30 days after treatment initiation, 60 days after treatment initiation and 90 days after treatment initiation",
                              "Baseline, 30 days after treatment initiation, 60 days after treatment initiation and 90 days after treatment initiation",
                              "Baseline, 30 days after treatment initiation, 60 days after treatment initiation and 90 days after treatment initiation",
                              "Baseline, 30 days after treatment initiation, 60 days after treatment initiation and 90 days after treatment initiation",
                              "Baseline, 30 days after treatment initiation, 60 days after treatment initiation and 90 days after treatment initiation"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT05243368"
                        ]
                  },
                  {
                        "Rank": 26,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [],
                        "SecondaryOutcomeMeasure": [
                              "Relative Wound Area Regression of 40% or More at 6 Week"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "6 week"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT02304588"
                        ]
                  }
            ]
      }
}